Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-012052

CFO and Treasurer sold 50,000 shares at an average $65.09 ($3,254,710)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. CFO and Treasurer 2021-02-16 Sale −22,684 $64.27 $1,457,923 927,316 I
Krognes Steve E. CFO and Treasurer 2021-02-16 Sale −10,199 $65.04 $663,323 917,117 I
Krognes Steve E. CFO and Treasurer 2021-02-16 Sale −16,616 $66.20 $1,099,996 900,501 I
Krognes Steve E. CFO and Treasurer 2021-02-16 Sale −501 $66.80 $33,468 900,000 I
Open-market sales · 50,000 sh · avg $65.09 · $3,254,710
Loading xslF345X03/doc4.xml…